Old Mission Capital’s AbbVie ABBV Stock Holding History

Old Mission Capital’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-2,449	Closed	-$397K	–	1438
2022 Q1	$397K	Buy	+2,449	New	+$356K	0.01%	792
2020 Q4	–	Sell	-2,767	Closed	-$242K	–	513
2020 Q3	$242K	Buy	+2,767	New	+$261K	0.02%	369
2018 Q3	–	Sell	-3,238	Closed	-$300K	–	248
2018 Q2	$300K	Buy	+3,238	New	+$316K	0.03%	163

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Old Mission Capital's ABBV Position: Q2 2022 in Review

Old Mission Capital sold out of AbbVie (ABBV) in Q2 2022, closing a stake of 2,449 shares — an estimated $397K sold.

Old Mission Capital first reported a position in ABBV in Q2 2018 and held it in 3 quarters. The position peaked at $397K in Q1 2022. 3,005 funds tracked by Wall St. Rank hold ABBV as of Q2 2022.

Old Mission Capital reported no remaining AbbVie position as of Q2 2022 after selling out during the quarter.
Old Mission Capital sold 2,449 AbbVie shares in Q2 2022, an estimated $397K.
Old Mission Capital first reported a position in AbbVie in Q2 2018 and held it in 3 quarters.
Old Mission Capital's AbbVie position peaked at $397K in Q1 2022.
3,005 funds tracked by Wall St. Rank held AbbVie as of Q2 2022.

Based on Old Mission Capital's 13F filing for Q2 2022, filed 5 Aug 2022.